# Nazzareno Galiè

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nazzareno-galie/

## Facts

| Field | Value |
| --- | --- |
| Citations | 90,322 |
| Field | Pulmonary Hypertension Research and Treatments |
| h-index | 109 |
| i10-index | 283 |
| Last Known Institution | Azienda USL di Bologna |
| OpenAlex ID | https://openalex.org/A5065469571 |
| ORCID iD | https://orcid.org/0000-0003-4271-8670 |
| Works | 868 |

## Researcher papers

Showing 12 of 14.

- [2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)](https://scholariq.org/papers/2019-esc-guidelines-for-the-diagnosis-and-management-of-acute-pulmonary-embolism/)
- [Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension-the-task/)
- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-2/)
- [2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism](https://scholariq.org/papers/2014-esc-guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism/)
- [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS](https://scholariq.org/papers/2017-esc-focused-update-on-dual-antiplatelet-therapy-in-coronary-artery-disease/)
- [Bosentan Therapy for Pulmonary Arterial Hypertension](https://scholariq.org/papers/bosentan-therapy-for-pulmonary-arterial-hypertension/)
- [ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)](https://scholariq.org/papers/esc-guidelines-for-the-management-of-grown-up-congenital-heart-disease-new/)
- [Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension](https://scholariq.org/papers/macitentan-and-morbidity-and-mortality-in-pulmonary-arterial-hypertension/)
- [Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial](https://scholariq.org/papers/continuous-subcutaneous-infusion-of-treprostinil-a-prostacyclin-analogue-in/)
- [Riociguat for the Treatment of Pulmonary Arterial Hypertension](https://scholariq.org/papers/riociguat-for-the-treatment-of-pulmonary-arterial-hypertension/)
- [Selexipag for the Treatment of Pulmonary Arterial Hypertension](https://scholariq.org/papers/selexipag-for-the-treatment-of-pulmonary-arterial-hypertension/)
- [Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era](https://scholariq.org/papers/reduction-of-hospitalizations-for-myocardial-infarction-in-italy-in-the-covid-19/)

## Researcher topics

- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Cardiovascular Issues in Pregnancy](https://scholariq.org/topics/cardiovascular-issues-in-pregnancy/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Vascular Anomalies and Treatments](https://scholariq.org/topics/vascular-anomalies-and-treatments-2/)

## Researcher university

- [Azienda USL di Bologna](https://scholariq.org/institutions/azienda-usl-di-bologna/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.